.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Deloitte
Citi
Cipla
Julphar
Dow
Farmers Insurance
Boehringer Ingelheim
Cantor Fitzgerald
Covington

Generated: September 19, 2017

DrugPatentWatch Database Preview

Clinigen Hlthcare Company Profile

« Back to Dashboard

What is the competitive landscape for CLINIGEN HLTHCARE, and what generic alternatives to CLINIGEN HLTHCARE drugs are available?

CLINIGEN HLTHCARE has three approved drugs.

There are two US patents protecting CLINIGEN HLTHCARE drugs.

There are thirty-three patent family members on CLINIGEN HLTHCARE drugs in sixteen countries.

Summary for Applicant: Clinigen Hlthcare

Patents:2
Tradenames:3
Ingredients:3
NDAs:3
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Clinigen Hlthcare
ETHYOL
amifostine
INJECTABLE;INJECTION020221-001Dec 8, 1995APRXYesYes► Subscribe► Subscribe ► Subscribe
Clinigen Hlthcare
ETHYOL
amifostine
INJECTABLE;INJECTION020221-002Sep 10, 1999DISCNNoNo► Subscribe► Subscribe ► Subscribe
Clinigen Hlthcare
FOSCAVIR
foscarnet sodium
INJECTABLE;INJECTION020068-001Sep 27, 1991APRXYesYes► Subscribe► Subscribe► Subscribe
Clinigen Hlthcare
TOTECT
dexrazoxane hydrochloride
INJECTABLE;INJECTION022025-001Sep 6, 2007RXYesYes► Subscribe► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Clinigen Hlthcare

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Clinigen Hlthcare
ETHYOL
amifostine
INJECTABLE;INJECTION020221-002Sep 10, 1999► Subscribe► Subscribe
Clinigen Hlthcare
ETHYOL
amifostine
INJECTABLE;INJECTION020221-001Dec 8, 1995► Subscribe► Subscribe
Clinigen Hlthcare
ETHYOL
amifostine
INJECTABLE;INJECTION020221-001Dec 8, 1995► Subscribe► Subscribe
Clinigen Hlthcare
ETHYOL
amifostine
INJECTABLE;INJECTION020221-002Sep 10, 1999► Subscribe► Subscribe
Clinigen Hlthcare
FOSCAVIR
foscarnet sodium
INJECTABLE;INJECTION020068-001Sep 27, 1991► Subscribe► Subscribe
Clinigen Hlthcare
FOSCAVIR
foscarnet sodium
INJECTABLE;INJECTION020068-001Sep 27, 1991► Subscribe► Subscribe
Clinigen Hlthcare
ETHYOL
amifostine
INJECTABLE;INJECTION020221-002Sep 10, 1999► Subscribe► Subscribe
Clinigen Hlthcare
FOSCAVIR
foscarnet sodium
INJECTABLE;INJECTION020068-001Sep 27, 1991► Subscribe► Subscribe
Clinigen Hlthcare
FOSCAVIR
foscarnet sodium
INJECTABLE;INJECTION020068-001Sep 27, 1991► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for CLINIGEN HLTHCARE drugs

Drugname Dosage Strength Tradename Submissiondate
amifostine
For Injection500 mg/vial
ETHYOL
4/16/2004

Non-Orange Book Patents for Clinigen Hlthcare

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,586,476 Methods for the treatment of nephro-disorders using aminothiol compounds► Subscribe
7,105,575Methods for the treatment of neuro- disorders using aminothiol compounds► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Clinigen Hlthcare Drugs

Country Document Number Estimated Expiration
Germany69834658► Subscribe
China1199644► Subscribe
Australia739068► Subscribe
Japan2006188532► Subscribe
World Intellectual Property Organization (WIPO)9929312► Subscribe
Spain2220424► Subscribe
China1283994► Subscribe
Austria326956► Subscribe
MexicoPA01009212► Subscribe
Australia1718499► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Deloitte
Chinese Patent Office
AstraZeneca
Queensland Health
Express Scripts
Novartis
UBS
Harvard Business School
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot